We are live on ! Find out more
AVM

Avalon Ventures Management Portfolio holdings

AUM $14.2M
1-Year Est. Return 9.35%
This Fund
S&P 500
This Quarter Est. Return
-25.23%
1 Year Est. Return
+9.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.2M
AUM Growth
-$4.81M
Cap. Flow
+$244K
Cap. Flow %
1.71%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
JANX icon
Janux Therapeutics
JANX
+$244K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 90.83%
2 Healthcare 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLTR icon
1
Kaltura
KLTR
$206M
$12.9M 90.83%
8,962,707
JANX icon
2
Janux Therapeutics
JANX
$925M
$1.3M 9.17%
53,300
+10,000
+23% +$244K

Similar funds

Avalon Ventures Management's Q3 2025 Portfolio in Review

As of Q3 2025, Avalon Ventures Management held 2 positions worth $14.2M, down 25% from $19M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. Avalon Ventures Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 91% of assets, down from 95% a quarter earlier, followed by Healthcare.

  • Avalon Ventures Management added most to Janux Therapeutics in Q3 2025, an estimated $244K increase.
  • Avalon Ventures Management's ten largest holdings make up 100% of its $14.2M portfolio in Q3 2025.
  • Avalon Ventures Management opened 0 new positions and closed 0 in Q3 2025.
  • Avalon Ventures Management's portfolio value fell 25% quarter-over-quarter to $14.2M.

Based on Avalon Ventures Management's 13F filing for Q3 2025, filed 13 Nov 2025.